Key Findings
The Europe clinical nutrition market is evaluated to project a CAGR of 4.63%, during the forecast period of 2019 to 2028. The surging awareness among patients regarding the availability of clinical nutrition, and the increasing incidence of chronic diseases are predicted to accelerate the region’s market growth.

Market Insights
The Europe clinical nutrition market is assessed across countries, namely, the United Kingdom, France, Russia, Italy, Germany, Poland, Belgium, and the rest of Europe. The market in France is expected to depict a steady demand for clinical nutrition, owing to solid consumer preferences, and the upsurge in precautionary measures, in view of the coronavirus pandemic. Moreover, the high prevalence of chronic diseases like diabetes, obesity, and heart diseases, incorporated with the country’s growing geriatric population, is expected to drive the demand for clinical nutrition.
According to an EU Commission study, among each member state, France accounts for the highest number of people with chronic diabetes. Although obesity in the country is relatively lower than most of the Organization for Economic Cooperation and Development (OECD) countries, the rates are rising steadily. As a result, aligning with these estimations, one in ten citizens is obese, and nearly 40% are overweight, including obese. The OCED projections also depict that the overweight rates will crease by 10%, over the next decade. Thus, the prevalence of chronic conditions and the general awareness of the advantages of dietary supplements amid the COVID-19 pandemic, is predicted to bolster the market for clinical nutrition in the region.

Competitive Insights
Eminent companies in the market include, BASF SE, Nestle Health Science, Abbott Laboratories, Baxter International Inc, Danone, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments